Chun-Ya Han
Amgen (United States)(US)
Publications by Year
Research Areas
Bone Metabolism and Diseases, Bone health and osteoporosis research, Bone health and treatments, Parathyroid Disorders and Treatments, Nutrition and Health in Aging
Most-Cited Works
- → Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones(2010)265 cited
- → A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair(2016)251 cited
- → Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibifity(1994)171 cited
- → Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene(1994)166 cited
- → Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury(2011)120 cited
- → Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus(2012)117 cited
- → Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats(2014)97 cited
- → Novel Genetic Models of Osteoporosis by Overexpression of Human RANKL in Transgenic Mice(2013)74 cited
- → Progressive Increases in Bone Mass and Bone Strength in an Ovariectomized Rat Model of Osteoporosis After 26 Weeks of Treatment With a Sclerostin Antibody(2014)71 cited
- → FGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPARα and PPARγ Agonists(2016)56 cited